Clinical platforms zero in on safety

KEM Clinicals is an update of Ariana Pharmas' Knowledge Extraction and Management platform, a decision-support tool for drug researchers. The new version supports clinical development and safety processes.

The update allows users to test hypotheses, and it generates them consistent with data relevant to trial objectives, according to an announcement. The solution uses such features as optimal inclusion/exclusion criteria in protocol design; early adverse event detection and characterization; identification of surrogate endpoints; and design of composite efficacy/safety endpoints.

Separately, TheraDoc has added six clinical and adverse drug event alert packages to its Expert System informatics platform. The alert bundles work with the platform to provide electronic surveillance of patient data from multiple hospital information sources.

- here's the KEM Clinicals release
- see the TheraDocs announcement

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.